Gemcitabine-induced myopathy

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 6, 2014, Pages 784-791

  Spielmann, Lionel ^a   Messer, Laurent ^b   Moreau, Paul ^b   Etienne, Elodie ^c   Meyer, Carole ^d   Sibilia, Jean ^a   Gottenberg, Jacques Eric ^a   Geny, Bernard ^e   Lannes, Béatrice ^a   Meyer, Alain ^a,e  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Service de Rhumatologie HÔpitaux de Colmar   (France)

^c Hospices civils   (France)

^d Service de Chirurgie Générale Digestive et Thoracique HÔpitaux de Colmar   (France)

^e PÔle de Pathologie Thoracique HÔpitaux Universitaire de Strasbourg Service de Physiologie et d'Explorations Fonctionnelles   (France)

Author keywords

Gemcitabine; Myopathy; Vasculopathy

Indexed keywords

AUTOANTIBODY; GEMCITABINE; PANCREATIN; PANCRELIPASE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; MERALGIA; MULTIPLE CYCLE TREATMENT; MYALGIA; MYOPATHY; PAIN; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; QUADRICEPS FEMORIS MUSCLE; RECTUS FEMORIS MUSCLE; VASTUS MEDIALIS MUSCLE; VERY ELDERLY; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; CASE REPORT; CHEMICALLY INDUCED; MUSCULAR DISEASES; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATIC NEOPLASMS; PATHOLOGY; SKELETAL MUSCLE; THIGH;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLE, SKELETAL; MUSCULAR DISEASES; PANCREATIC NEOPLASMS; QUADRICEPS MUSCLE; THIGH;

EID: 84902548616     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.11.009     Document Type: Article

References (28)

1. Welsh J.S., Torre T.G., DeWeese T.L., O'Reilly S. Radiation myositis. Ann Oncol 1999, 10:1105-1108.
2. Ganem G., Solal-Celigny P., Joffroy A., Tassy D., Delpon A., Dupuis O. Radiation myositis: the possible role of gemcitabine. Ann Oncol 2000, 11:1615-1616.
3. Fogarty G., Ball D., Rischin D. Radiation recall reaction following gemcitabine. Lung Cancer 2001, 33:299-302.
4. Jeter M.D., Jänne P.A., Brooks S., Burstein H.J., Wen P., Fuchs C.S., et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002, 53:394-400.
5. Friedlander P.A., Bansal R., Schwartz L., Wagman R., Posner J., Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004, 100:1793-1799.
6. Fakih M.G. Gemcitabine-induced rectus abdominus radiation recall. JOP 2006, 7:306-310.
7. Squire S., Chan M., Feller E., Mega A., Gold R. An unusual case of gemcitabine-induced radiation recall. Am J Clin Oncol 2006, 29:636.
8. Horan G., Smith S.L., Podd T.J. Gemcitabine-induced radiation necrosis of the pectoralis major muscle. Clin Oncol (R Coll Radiol) 2006, 18:85.
9. Alco G., Igdem S., Dincer M., Tecimer C., Senturk R., Vural M., et al. Gemcitabine induced radiation recall myositis: report of two cases. Uhod-Uluslar Hematol 2009, 19:249-253.
10. O'Regan K.N., Nishino M., Armand P., Kelly P.J., DG-I Hwang, Di Salvo D. Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature. J Ultrasound Med 2010, 29:1499-1502.
11. Wong K.M., Khanna M., Wu R.C., Hedley D.W. Gemcitabine-induced acute myositis in a patient with duodenal cancer. Clin Oncol (R Coll Radiol) 2011, 23:492-493.
12. Eckardt M.A., Bean A., Selch M.T., Federman N. A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome. J Pediatr Hematol Oncol 2013, 35:156-161.
13. Pentsova E., Liu A., Rosenblum M., O'Reilly E., Chen X., Hormigo A. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol 2012, 106:15-21.
14. Burris H.A., Hurtig J. Radiation recall with anticancer agents. Oncologist 2010, 15:1227-1237.
15. Voorburg A.M.C.J, van Beek FT, Slee P.H.T.J, Seldenrijk C.A., Schramel F.M.N.H Vasculitis due to gemcitabine. Lung Cancer 2002, 36:203-205.
16. Ardavanis A.S., Ioannidis G.N., Rigatos G.A. Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel. Anticancer Res 2005, 25:523-525.
17. Kalmadi S., McNeill G., Davis M., Peereboom D., Adelstein D., Mekhail T. Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer. Med Oncol 2006, 23:507-513.
18. Geffen D.B., Horowitz J. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone. Isr Med Assoc J 2000, 2:552-553.
19. Vatca M.-A., Tejwani sheela, Yates todd Ischemic myositis in a diabetic patient receiving chemotherapy. Community Oncol 2009, 6:69-79.
20. Syrios J., Kechagias G., Xynos I.D., Gamaletsou M.N., Papageorgiou A., Agrogiannis G., et al. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol 2011, 11:33.
21. Miller F.W., Hess E.V., Clauw D.J., Hertzman P.A., Pincus T., Silver R.M., et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000, 43:243-249.
22. Jain A., Sharma M.C., Sarkar C., Bhatia R., Singh S., Handa R. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies. Arch Pathol Lab Med 2007, 131:1070-1076.
23. Van der Pas J., Hengstman G.J.D., ter Laak H.J., Borm G.F., van Engelen B.G.M. Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatr 2004, 75:136-139.
24. Trallero-Araguás E., Rodrigo-Pendás J.Á., Selva-O'Callaghan A., Martínez-Gómez X., Bosch X., Labrador-Horrillo M., et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 2012, 64:523-532.
25. Dasanu C.A. Gemcitabine: vascular toxicity and prothrombotic potential. Expert Opin Drug Saf 2008, 7:703-716.
26. Ma L., Francia G., Viloria-Petit A., Hicklin D.J., du Manoir J., Rak J., et al. In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy. Cancer Res 2005, 65:5365-5373.
27. Kuenen B.C., Levi M., Meijers J.C.M., van Hinsbergh V.W.M., Berkhof J., Kakkar A.K., et al. Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416. J Clin Oncol 2003, 21:2192-2198.
28. Krisinger M.J., Goebeler V., Lu Z., Meixner S.C., Myles T., Pryzdial E.L.G., et al. Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. Blood 2012, 120:1717-1725.